Replies to post #13044 on Radient Pharmaceuticals Corporation fka RXPC

[waterchaser]

It's possible that you have not researched the cost of shorting stinky pinky stocks. The cost to short RXPC is prohibitive.

[Gold Seeker]

Cashking, no one shorts this type of penny stock. If you look at the actual bi-weekly short report, I think it last stated 13 shares. Since this stock has been selling at .0001, about 4 billion were sold and most of those would be happy just to get their money back.